Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells

被引:97
作者
Blomqvist, Maria [1 ]
Rhost, Sara [1 ]
Teneberg, Susann [2 ]
Lofbom, Linda [1 ]
Osterbye, Thomas [3 ]
Brigl, Manfred [4 ,5 ,6 ]
Mansson, Jan-Eric [7 ]
Cardell, Susanna L. [1 ]
机构
[1] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, S-40530 Gothenburg, Sweden
[3] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark
[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, S-40530 Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
Antigen presentation/processing; Autoimmunity; CD1; molecules; NKT cells Self/non-self discrimination; T-CELLS; ANTIGEN PRESENTATION; RECOGNITION; INVOLVEMENT; DISTINCT; COMPLEX; GLYCOLIPIDS; LANGERHANS; PREVENTION; RESOLUTION;
D O I
10.1002/eji.200839001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The glycosphingolipid sulfatide (SO3-3Gal beta 1Cer) is a demonstrated ligand for a subset of CD1d-restricted NKT cells, which could regulate experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis, as well as tumor immunity and experimental hepatitis. Native sulfatide is a mixture of sulfatide isoforms, i.e. sulfatide molecules with different long-chain bases and fatty acid chain lengths and saturation. Here, we demonstrate that sulfatide-specific CD1d-restricted murine NKT hybridomas recognized several different sulfatide isoforms. These included the physiologically relevant isoforms C24:1 and C24:0, major constituents of the myelin sheet of the nervous system, and C16:0, prominent in the pancreatic islet beta-cells. The most potent sulfatide isoform was lysosulfatide (lacking a fatty acid). Shortened fatty acid chain length (C24:1 versus C18:1), or saturation of the long fatty acid (C24:0), resulted in reduced stimulatory capacity, and fatty acid hydroxylation. abolished the response. Moreover, sulfatide was not responsible for the natural autoreactivity toward splenocytes by XV19 T hybridoma cells. Our results reveal a promiscuity in the recognition of sulfatide isoforms by a CD1d-restricted NKT-cell clone, and suggest that sulfatide, a major component of the myelin sheet and pancreatic beta-cells, is one of several natural ligands for type II CD1d-restricted NKT cells.
引用
收藏
页码:1726 / 1735
页数:10
相关论文
共 57 条
[1]   Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis [J].
Ambrosino, Elena ;
Terabe, Masaki ;
Halder, Ramesh C. ;
Peng, Judy ;
Takaku, Shun ;
Miyake, Sachiko ;
Yamamura, Takashi ;
Kumar, Vipin ;
Berzofsky, Jay A. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (08) :5126-5136
[2]   CD1 antigen presentation: how it works [J].
Barral, Duarte C. ;
Brenner, Michael B. .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (12) :929-941
[3]  
Behar SM, 1999, J IMMUNOL, V162, P161
[4]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[5]   The biology of NKT cells [J].
Bendelac, Albert ;
Savage, Paul B. ;
Teyton, Luc .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :297-336
[6]   In vivo administration of the C16:o fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose-stimulated insulin secretion in Zucker fatty (fa/fa) rats [J].
Blomqvist, M ;
Carrier, M ;
Andrews, T ;
Pettersson, K ;
Månsson, JE ;
Rynmark, BM ;
Fredman, P ;
Buschard, K .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (02) :158-166
[7]   Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity [J].
Bricard, G. ;
Porcelli, S. A. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (14) :1824-1840
[8]  
Brossay L, 1998, J IMMUNOL, V160, P3681
[9]   Involvement of sulfatide in beta cells and type 1 and type 2 diabetes [J].
Buschard, K ;
Blomqvist, M ;
Osterbye, T ;
Fredman, P .
DIABETOLOGIA, 2005, 48 (10) :1957-1962
[10]  
BUSCHARD K, 1994, DIABETOLOGIA, V37, P1000